Cargando…

Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation

Inhibitors of coagulation factor XIa (FXIa) are currently being investigated as potential anticoagulant therapies. We hypothesize that circulating FXIa could be a potential target for these therapies. Using previous analyses of FXIa impurities in immune globulin products involved in thrombotic adver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parunov, Leonid A., Liang, Yideng, Lu, Qijin, Shibeko, Alexey M., Tucker, Erik I., Lee, Timothy K., Ataullakhanov, Fazoil I., Scott, Dorothy E., Ovanesov, Mikhail V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Thrombosis and Hemostasis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250917/ https://www.ncbi.nlm.nih.gov/pubmed/36724509 http://dx.doi.org/10.1182/bloodadvances.2022008743

Ejemplares similares

Noncanonical Sonic Hedgehog signaling amplifies platelet reactivity and thrombogenicity
por: Tiwari, Arundhati, et al.
Publicado: (2022)

Detecting factor XIa in immune globulin products: Commutability of international reference materials for traditional and global hemostasis assays
por: Liang, Yideng, et al.
Publicado: (2020)

A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation
por: Wan, Jun, et al.
Publicado: (2022)

Structural, functional, and immunogenicity implications of F9 gene recoding
por: Katneni, Upendra K., et al.
Publicado: (2022)

Crucial roles of red blood cells and platelets in whole blood thrombin generation
por: Sun, Siyu, et al.
Publicado: (2023)

Differential impact of tamoxifen and aromatase inhibitors on thrombin generation: the prospective HEMOBREAST cohort
por: Blondon, Marc, et al.
Publicado: (2022)

Thrombin-mediated activation of PAR1 enhances doxorubicin-induced cardiac injury in mice
por: Grover, Steven P., et al.
Publicado: (2022)

Cryo-EM structure of coagulation factor V short
por: Mohammed, Bassem M., et al.
Publicado: (2023)

Lower-leg injury and knee arthroscopy have distinct effects on coagulation
por: Touw, Carolina E., et al.
Publicado: (2022)

Mechano-covalent protection of coagulation factor VIII by von Willebrand factor
por: Butera, Diego, et al.
Publicado: (2022)

Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia
por: Hisada, Yohei, et al.
Publicado: (2023)

Traumatic vessel injuries initiating hemostasis generate high shear conditions
por: Yakusheva, Alexandra A., et al.
Publicado: (2022)

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Role of ribosomal RNA released from red cells in blood coagulation in zebrafish and humans
por: Alharbi, Abdulmajeed, et al.
Publicado: (2021)

Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19
por: Henderson, Michael W., et al.
Publicado: (2022)

Structure of coagulation factor VIII bound to a patient-derived anti–C1 domain antibody inhibitor
por: Childers, Kenneth C., et al.
Publicado: (2023)

Combined thrombogenic effects of vessel injury, pregnancy and procoagulant immune globulin administration in mice
por: Xu, Yanqun, et al.
Publicado: (2020)

Comparative Thrombin Generation in Animal Plasma: Sensitivity to Human Factor XIa and Tissue Factor
por: Liang, Yideng, et al.
Publicado: (2023)

Factor XII plays a pathogenic role in organ failure and death in baboons challenged with Staphylococcus aureus
por: Silasi, Robert, et al.
Publicado: (2021)

COVID-19 coagulopathy, thrombosis, and bleeding
por: Chan, Noel C., et al.
Publicado: (2020)

The prevalence of thrombocytopenia in patients with acute cancer-associated thrombosis
por: Hsu, Charles, et al.
Publicado: (2022)

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
por: Orsi, Fernanda A., et al.
Publicado: (2019)

Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study
por: Carney, Brian J., et al.
Publicado: (2021)

Pregnancy in women with an inferior vena cava filter: a tertiary center experience and overview of the literature
por: Bistervels, Ingrid M., et al.
Publicado: (2021)

Effect of pH on thrombin activity measured by calibrated automated thrombinography
por: Jackson, Joseph W., et al.
Publicado: (2020)

Extent of intravital contraction of arterial and venous thrombi and pulmonary emboli
por: Khismatullin, Rafael R., et al.
Publicado: (2022)

Histidine-rich glycoprotein attenuates catheter thrombosis
por: Malik, Rida A., et al.
Publicado: (2023)

First randomized evaluation of safety, pharmacodynamics, and pharmacokinetics of BAY 1831865, an antibody targeting coagulation factor XI and factor XIa, in healthy men
por: Nowotny, Bettina, et al.
Publicado: (2022)

Cleavage of talin by calpain promotes platelet-mediated fibrin clot contraction
por: Fong, Karen P., et al.
Publicado: (2021)

Synonymous ADAMTS13 variants impact molecular characteristics and contribute to variability in active protein abundance
por: Jankowska, Katarzyna I., et al.
Publicado: (2022)

Differences in wild-type– and R338L-tenase complex formation are at the root of R338L-factor IX assay discrepancies
por: Foley, Jonathan H., et al.
Publicado: (2022)

VWF–ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion
por: Fogarty, Helen, et al.
Publicado: (2023)

A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia
por: Lee, Christine S.M., et al.
Publicado: (2022)

The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies
por: Longstaff, Colin, et al.
Publicado: (2011)

Activated protein C cofactor function of protein S: a critical role for Asp95 in the EGF1-like domain
por: Andersson, Helena M., et al.
Publicado: (2010)

Harmful or Physiologic: Diagnosing Fibrinolysis Shutdown in a Trauma Cohort With Rotational Thromboelastometry
por: Gomez-Builes, J. Carolina, et al.
Publicado: (2018)

Platelets inhibit apoptotic lung epithelial cell death and protect mice against infection-induced lung injury
por: Bain, William, et al.
Publicado: (2019)

Targeting complement activation in COVID-19
por: Kulkarni, Hrishikesh S., et al.
Publicado: (2020)

Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
por: Yu, Jia, et al.
Publicado: (2020)

Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study
por: Hill, Jason B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t29ausiackirr9jc96e9bt1thf